PHT5247 - Disorders of the Bladder and Urethra
Overview of Bladder and Urethra Disorders
Focus on voiding dysfunction associated with neurological pathology.
Term: Neurogenic bladder disorder or neurogenic lower urinary tract dysfunction.
Voiding Dysfunction
Common problem linked with various neurological diseases.
Costly and detrimental to quality of life, particularly among older adults requiring long-term care.
Causes of Voiding Dysfunction
Damage to nerves affecting bladder function can result in voiding dysfunction.
Neurological conditions associated include:
Cerebrovascular accidents (strokes)
Dementia
Parkinson's disease
Multiple sclerosis
Brain tumors
Lesions in the spinal cord can mimic reflexive bladder characteristics seen in cerebral injuries.
Conditions causing such lesions include:
Spinal cord injury
Herniated intervertebral disks
Vascular lesions
Spinal cord tumors
Urinary Incontinence
Defined as:
Involuntary loss of urine, significant enough to be problematic.
Occurs mainly when bladder pressure exceeds sphincter resistance.
Types of Urinary Incontinence
Functional incontinence:
Bladder function is normal but mind and body fail to coordinate effectively.
Can arise from mobility and access limitations (e.g., confined to a wheelchair or requiring a walker).
Stress incontinence:
Support for the bladder or urethra is weakened or damaged; the bladder remains normal.
Triggered by pressure on the bladder from actions like coughing, sneezing, laughing, lifting, or exercising.
Resultant pelvic floor musculature lacks the strength to counteract the increased urethral or bladder pressure.
Urge incontinence:
Characterized by involuntary contraction of the detrusor muscle—smooth muscle of the bladder wall.
Occurs with a strong desire to void, often leading to immediate loss of urine, with no known infection or other pathology.
Potential causes:
Medications
Alcohol
Bladder infections
Bladder tumors
Neurogenic bladder conditions
Bladder outlet obstructions
Overflow incontinence:
Results from overdistension of the bladder, where it fails to empty completely.
The urine leaks or dribbles out; the patient experiences no sensation of fullness or emptying.
In men, often secondary to obstruction from:
Prostatic hyperplasia
Prostatic carcinoma
Urethral stricture
Treatment Options
Antimuscarinics:
Help reduce bladder hypotonicity by inhibiting detrusor muscle contractions.
Benefits:
Allow more normal bladder filling
Reduce frequency of urination
Decrease chances of incontinence
Side effects include:
Dry mouth
Constipation
Blurred vision
Potential drowsiness, especially when combined with other medications
Beta-3 agonists:
Used to inhibit bladder muscle contractions, providing an additional treatment pathway.
Botox (Botulinum toxin A):
Involves injecting a neurotoxin to relax the bladder muscles.
Used when patients do not respond to other treatment options for urinary incontinence and overactive bladder.
Considerations:
Watch for adverse effects, including urinary retention, urinary tract infections, and increased blood pressure.
Other Therapeutic Approaches
Diet modification:
Aim to avoid bladder irritants such as coffee and alcohol.
Bladder training and behavioral therapy:
Techniques aimed at improving voiding habits and managing symptoms.
Pelvic floor strengthening:
Exercises that enhance the supportive structures of the bladder and urethra.